1. Introduction of Glycine
Glycine, with the IUPAC Name of 2-Aminoacetic acid, is one kind of white crystalline powder. This chemical belongs to the Classification Code which include Component of irrigating solution; Glycine Agents; Mutation data; Neurotransmitter Agents.
2. Properties of Glycine
Glycine has the following property datas: (1)Melting point: 240 °C; (2)Index of Refraction: 1.46; (3)Molar Refractivity: 16.41 cm3; (4)Molar Volume: 59.8 cm3; (5)Surface Tension: 54.4 dyne/cm; (6)Density: 1.254 g/cm3; (7)Flash Point: 99.5 °C; (8)Enthalpy of Vaporization: 52.63 kJ/mol; (9)Boiling Point: 240.9 °C at 760 mmHg; (10)Vapour Pressure: 0.0123 mmHg at 25°C.
3. Structure Descriptors of Glycine
You could convert the following datas into the molecular structure:
InChI: InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
InChIKey: InChIKey=DHMQDGOQFOQNFH-UHFFFAOYSA-N
Smiles: C(=O)(CN)O
4. Uses of Glycine
Glycine has many uesage:
1).Animal and human foodstuffs:
use an additive in pet food and animal feed. For humans, glycine is used as a sweetener/taste enhancer. such as Food supplements and protein drinks.some drug formulations use glycine to improve gastric absorption.
2).Chemical feedstock
Glycine is an intermediate in the synthesis of a variety of chemical products. It is used in the manufacture of the herbicide Glyphosate. Glyphosate (N-(phosphonomethyl) glycine) is a non-selective systemic herbicide used to kill weeds, especially perennials and broadcast or used in the cut-stump treatment as a forestry herbicide. Initially, Glyphosate was sold only by Monsanto under the Monsanto tradename Roundup, but is no longer under patent
3).Cosmetics and other applications:
Glycine can be used as a buffering agent in analgesics, antacids, cosmetics, antiperspirants, and toiletries.Many products use glycine or its derivatives, such as the production of rubber sponge products, fertilizers, metal complexants.
5. Safety information of Glycine
Risk Statements of Glycine (CAS NO.56-40-6): 33
R33: Danger of cumulative effects.
Safety Statements: 22-24/25
S22: Do not breathe dust.
S24/25: Avoid contact with skin and eyes.
6. Production of Glycine
Glycine (CAS NO.56-40-6)e is manufactured by treating chloroacetic acid with ammonia industrially
ClCH2COOH + 2 NH3 → H2NCH2COOH + NH4Cl
It also can be produced via the Strecker amino acid synthesis.
7. Toxicity information of Glycine
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
cat |
LDLo |
intravenous |
3gm/kg (3000mg/kg) |
BEHAVIORAL: FOOD INTAKE (ANIMAL)
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: ATAXIA |
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 306, 1942. |
mouse |
LD50 |
intraperitoneal |
4450mg/kg (4450mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
mouse |
LD50 |
intravenous |
2370mg/kg (2370mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
mouse |
LD50 |
oral |
4920mg/kg (4920mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
mouse |
LD50 |
subcutaneous |
5060mg/kg (5060mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
rat |
LD50 |
intravenous |
2600mg/kg (2600mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
rat |
LD50 |
oral |
7930mg/kg (7930mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |
rat |
LD50 |
subcutaneous |
5200mg/kg (5200mg/kg) |
|
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 5, Pg. 1502, 1977. |